22.2 C
Vientiane
Tuesday, November 4, 2025
spot_img
Home Blog Page 900

Aphranel® shines in IMCAS China 2025 as Platinum Sponsor

SHANGHAI, Aug. 4, 2025 /PRNewswire/ — Aphranel, China’s leading innovator of regenerative aesthetics medicine, recently made waves at IMCAS China 2025 with its 36㎡ platinum sponsorship booth, hosted a 60-minute scientific symposium and 30-minute live-case with its breakthrough product Aphranel® MagiCCrystal CaHA Filler.

IMCAS leadership including Congress Chair Prof. Cui Haiyan, IMCAS Paris Chairmen Dr. Cartier and Dr. Garson visited Aphranel, recognizing its significant contributions to global industry of regenerative aesthetics medicine. This high-profile exhibiting in IMCAS China, demonstrated the Aphranel’s growing influence on the advanced anti-aging solutions in the global market.


About Aphranel

Aphranel® is a high-profile medical aesthetics brand under Shanghai MOYOM Biotechnology, dedicated to advancing global aesthetics technology through cutting-edge biomaterial innovation.

Xsolla, In Collaboration With KRAFTON, Releases The “Abyss Of Dungeons” Web Shop To Fuel Direct-To-Player Growth

Abyss Of Dungeons Combines Medieval Dark Fantasy With Extraction-Style RPG Gameplay, Now Bolstered By A Global Web Shop Built In Partnership With Xsolla


LOS ANGELES, USA – Media OutReach Newswire – 4 August 2025 – Xsolla, a leading global video game commerce company, announces its latest collaboration with KRAFTON: a dedicated Web Shop for Abyss of Dungeons, the newest dark fantasy extraction Role-Playing Game (RPG) from Bluehole Studio.

Abyss of Dungeon
Abyss of Dungeon

In a treacherous medieval underworld, Abyss of Dungeons fuses high-stakes survival with immersive dungeon-crawling combat and player-driven progression. Currently available across select markets, including the US, Canada, Indonesia, Thailand, Brazil, and Mexico, the game has attracted a loyal community drawn to its blend of PvP and PvE gameplay, strategic class-based combat, and ever-present risk-reward mechanics.

To support KRAFTON’s community-first strategy, Xsolla delivered a custom-built Web Shop experience that enables players to purchase exclusive in-game content directly through a branded store outside traditional app stores.

Key features of Abyss of Dungeons include:

  • Medieval Fantasy Extraction RPG: Brave dungeon mazes filled with lethal monsters and rival adventurers while escaping the tightening grip of the Dark Swarm.
  • PvP and PvE Combat: Fight enemies and players alike for treasure, choose to hunt or risk being hunted.
  • Diverse Class System: Six unique classes, Fighter, Barbarian, Rogue, Ranger, Cleric, and Wizard, each with distinct skills and tactical roles.
  • Strategic Party Play: Form parties, battle through the darkness together, and pursue legendary loot.
  • Progressive Power Growth: Escape dungeons to level up, master new weapons, and become a dungeon legend.

“KRAFTON’s Abyss of Dungeons exemplifies what’s possible when you blend premium gameplay with a smart, phased launch strategy,” said Chris Hewish, President of Xsolla. “We’re proud to power their direct-to-player approach with our Web Shop and Partner Network solutions, helping them deliver exclusive content and activate influencers worldwide.”

To support KRAFTON’s strategic goals of community growth and marketing efficiency, Xsolla collaborated closely with the development team to build and deploy the Abyss of Dungeons Web Shop, which launched in select markets on June 11, 2025. This shop offers exclusive bundles and in-game currency while integrating seamlessly with KRAFTON’s existing systems without requiring months of additional engineering effort.

Highlights of the collaboration:

  • Fast Time-to-Market: Launched with Xsolla’s Web Shop template and support, minimizing development overhead.
  • Exclusive Storefront Content: Offers unique bundles to incentivize direct purchases.
  • Global Reach: Provides access to 1,000+ payment methods through Xsolla’s infrastructure.
  • Influencer Integration: Leverages the Xsolla Partner Network (XPN) to onboard local creators and amplify reach.

“Working with Xsolla allowed us to move quickly and strategically,” said KS Lee | VP, Head of Publishing Div. 4. “This Web Shop solution helped us create a scalable direct-to-player foundation, while the XPN creators brought authentic engagement from key markets. This partnership allowed us to grow while keeping control over our vision.”

Explore the Abyss of Dungeons Web Shop here: https://abyssofdungeons.krafton.com/en

Hashtag: #Xsolla

The issuer is solely responsible for the content of this announcement.

About Xsolla

Xsolla is a leading global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world.

Vipshop to Announce Second Quarter 2025 Financial Results on August 14, 2025

GUANGZHOU, China, Aug. 4, 2025 /PRNewswire/ — Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands in China (“Vipshop” or the “Company”), today announced that it plans to release its second quarter 2025 financial results on Thursday, August 14, 2025, before the US market open.

The Company will hold a conference call on Thursday, August 14, 2025 at 7:30 am US Eastern Time, 7:30 pm Beijing Time to discuss the financial results.

All participants wishing to join the conference call must pre-register online using the link provided below.

Registration Link:
https://register-conf.media-server.com/register/BI2192d872e0794484950ff9361d783729

Once pre-registration has been completed, each participant will receive dial-in numbers and a unique access PIN via email. To join the conference, participants should use the dial-in details followed by the PIN code.

A live webcast of the earnings conference call can be accessed at https://edge.media-server.com/mmc/p/q2wjofki. An archived webcast will be available at the Company’s investor relations website at http://ir.vip.com.           

About Vipshop Holdings Limited

Vipshop Holdings Limited is a leading online discount retailer for brands in China. Vipshop offers high quality and popular branded products to consumers throughout China at a significant discount to retail prices. Since it was founded in August 2008, the Company has rapidly built a sizeable and growing base of customers and brand partners. For more information, please visit https://ir.vip.com/

Investor Relations Contact

Tel: +86 (20) 2233-0732
Email: IR@Vipshop.com

 

Yalla Group Limited to Report Second Quarter 2025 Financial Results on August 11, 2025 Eastern Time

DUBAI, UAE, Aug. 4, 2025 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced that it will report its unaudited financial results for the second quarter 2025 after the U.S. market closes on Monday, August 11, 2025.

Yalla Group Limited will hold a conference call on Monday, August 11, 2025, at 8:00 PM Eastern Time, 4:00 AM Dubai Time on Tuesday, August 12, 2025, or 8:00 AM Beijing Time on Tuesday, August 12, 2025, to discuss the financial results. Listeners may access the call by dialing the following numbers:

United States Toll Free: 

+1-888-317-6003

International:

+1-412-317-6061

United Arab Emirates Toll Free:

80-003-570-3598

Mainland China Toll Free:

400-120-6115

Hong Kong Toll Free: 

800-963-976

Access Code:

5144068

The replay will be accessible through August 18, 2025, by dialing the following numbers:

United States Toll Free:

+1-877-344-7529

International:

+1-412-317-0088

Access Code:

1658736

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https://ir.yalla.com.

About Yalla Group Limited

Yalla Group Limited is the largest MENA-based online social networking and gaming company, in terms of revenue in 2022. The Company operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games, popular in MENA, with in-game voice chat and localized Majlis functionality. Building on the success of Yalla and Yalla Ludo, the Company continues to add engaging new content, creating a regionally-focused, integrated ecosystem dedicated to fulfilling MENA users’ evolving online social networking and gaming needs. Through its holding subsidiary, Yalla Game Limited, the Company has expanded its capabilities in mid-core and hard-core games in the MENA region, leveraging its local expertise to bring innovative gaming content to its users. In addition, the growing Yalla ecosystem includes YallaChat, an IM product tailored for Arabic users, WeMuslim, a product that supports Arabic users in observing their customs, and casual games such as Yalla Baloot and 101 Okey Yalla, developed to sustain vibrant local gaming communities in MENA. Yalla is also actively exploring outside of MENA with Yalla Parchis, a Ludo game designed for the South American markets. Yalla’s mobile applications deliver a seamless experience that fosters a sense of loyalty and belonging, establishing highly devoted and engaged user communities through close attention to detail and localized appeal that profoundly resonates with users.

For more information, please visit https://ir.yalla.com.

Investor Relations Contact

Yalla Group Limited
Investor Relations
Kerry Gao – IR Director
Tel: +86-571-8980-7962
Email: ir@yalla.com

Piacente Financial Communications
Jenny Cai
Tel: +86-10-6508-0677
Email: yalla@tpg-ir.com

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
Email: yalla@tpg-ir.com

Kuaishou Technology to Report 2025 Second Quarter and Interim Financial Results on August 21, 2025

HONG KONG, Aug. 4, 2025 /PRNewswire/ — Kuaishou Technology (“Kuaishou” or the “Company”; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, today announced that it will report its unaudited consolidated results for the second quarter and half year ended June 30, 2025, after the Hong Kong market closes on Thursday, August 21, 2025.

The Company’s management will host a conference call on Thursday, August 21, 2025, at 7:00 PM Beijing Time (7:00 AM U.S. Eastern Time) to discuss the results.

Participants are required to pre-register for the conference call at:

Chinese Line (Mandarin):
https://s1.c-conf.com/diamondpass/10048379-hy76t5.html 

English Simultaneous Interpretation Line (listen-only mode):
https://s1.c-conf.com/diamondpass/10048376-gs71de.html

Participants can choose between the Chinese and English simultaneous interpretation options for pre-registration above. Please note that the English simultaneous interpretation option will be in listen-only mode. Upon registration, participants will receive an email containing conference call dial-in details, event passcode, and a unique registrant ID. This information will allow you to gain immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

Additionally, live, and archived webcasts of the conference call, for both Chinese and English simultaneous interpretation, will be available on the Company’s investor relations website at https://ir.kuaishou.com.

Replays of the conference call will be available until August 28, 2025 via the following dial-in details:

Dial-in Numbers

Mainland China:

400 1209 216

Hong Kong:

800 930 639

US/Canada:

1855 883 1031

Chinese conference ID:

10048379

English simultaneous interpretation conference ID: 

10048376

About Kuaishou

Kuaishou is a leading content community and social platform in China and globally, committed to becoming the most customer-obsessed company in the world. Kuaishou uses its technological backbone, powered by cutting-edge AI technology, to continuously drive innovation and product enhancements that enrich its service offerings and application scenarios, creating exceptional customer value. Through short videos and live streams on Kuaishou’s platform, users can share their lives, discover goods and services they need and showcase their talent. By partnering closely with content creators and businesses, Kuaishou provides technologies, products, and services that cater to diverse user needs across a broad spectrum of entertainment, online marketing services, e-commerce, local services, gaming, and much more. For more information, please visit https://ir.kuaishou.com.

For investor and media inquiries, please contact:

Kuaishou Technology
Investor Relations
Email: ir@kuaishou.com

 

Oudomxay Cracks Down on Illegal Venues, Arrests 73 Sex Workers

Oudomxay Cracks Down on Illegal Venues, Arrests 73 Sex Workers
The arrested sex workers (photo credit: Lao Security News)

Oudomxay Provincial Police have arrested 73 sex workers during a large-scale operation targeting illegal establishments in Namo district.

AXA Launches “AXA Health Concierge” Delivering a One-Stop Health Management Solution Across Hong Kong and Mainland China

First-ever cross-border Green Medical Pass

Integrating resources from both regions for efficient access to healthcare services

HONG KONG, Aug. 4, 2025 /PRNewswire/ — AXA Hong Kong and Macau (“AXA”) today announced the launch of its new “AXA Health Concierge” service, providing eligible customers[1] with a comprehensive, one-stop health management solution across Hong Kong and Mainland China. This initiative introduces the pioneering cross-border “Green Medical Pass,”[2], [3] offering priority access to medical appointments through a network of over 2,000 healthcare providers, to assist customers in obtaining medical resources from both locations efficiently. This service offers a range of professional medical support, including recommending specialists to facilitate early treatment, second medical opinion, appointment scheduling for both Western and traditional Chinese medicine resources, and ongoing support and follow-up during recovery, delivering more diverse and convenient healthcare options for customers.

Hong Kong’s healthcare system is facing significant strain. According to the latest statistics from the Hospital Authority, waiting time for specialist outpatient services have reached record high[4], with some in-demand services exceeding two years. In recent years, Mainland China’s healthcare sector has made significant advancements in quality, efficiency, and the adoption of cutting-edge technologies. Many institutions now offer internationally benchmarked services delivered by highly qualified medical professionals, making cross-border healthcare an increasingly attractive option for Hong Kong residents. In 2023 alone, Shenzhen provided over 700,000 medical consultations for Hong Kong residents, according to the Shenzhen Health Commission[5].

Janet Lee, Chief Life and Health Insurance Officer of AXA Hong Kong and Macau, said, “After the pandemic, cross-border interactions between Hong Kong and Mainland China have become increasingly frequent, with growing number of Hong Kong residents seeking medical services in the Mainland. As healthcare in Mainland China rapidly advance, cross-border medical services have expanded from initial services like dental care and health check-ups to specialist consultations and surgical procedures—such as dermatology, gynecology, gastroscopy and cancer treatments. In response to strong market demand, we have introduced the ‘AXA Health Concierge’ service, integrating high-quality medical resources across the Greater Bay Area and Hong Kong to leverage complementary strengths. This provides customers with more diverse and precise healthcare options, facilitating earlier intervention, reducing suffering, and improving medical outcomes. We believe true protection goes beyond post-treatment claims – it covers proactive prevention, timely treatment, and comprehensive post-recovery support throughout the entire healthcare journey. Looking ahead, we will continue to innovate and provide professional, high-quality protection to support every customer’s health and wellbeing.”

Three key services highlights:

  1. Pioneering Cross-Border Green Medical Pass
    AXA introduces the market first [6]cross-border Green Medical Pass across Hong Kong and Mainland China, covering over 2,000 medical institutions, including more than 500 experienced network doctors and over 30 specialist services. Customers can enjoy priority arrangement for designated hospitals admissions or outpatient services, significantly reducing waiting times, ensuring timely diagnosis and treatment, enhancing overall healthcare efficiency and improving patient outcomes.
  2. Professional Medical Advice and Cross-Border Support
    The “AXA Health Concierge” service offers professional medical advice to address customers’ health-related queries and provide relevant information on symptoms and wellness. Depending on individual needs, the service can also recommend suitable specialists, facilitate timely medical consultations, and offer second medical opinion. Ongoing support and follow-up are provided throughout the recovery process. The service has also been extended to cities across the Greater Bay Area, enabling customers seeking cross-border medical care to access top-tier healthcare resources and professional support with ease.
  3. Market-first Family Medical Privileges
    AXA cares for the health of both customers and their families, eligible policyholders can enjoy a 10% discount on outpatient consultations, while insured members under designated medical plans are entitled to up to 30% discount[7]. In a market-first[8] initiative, this outpatient consultation discount is also extended to the policyholders of all individual life products and/or the insured’s immediate family members[9]. By simply registering through Emma by AXA App, family members can access a 10% discount on consultation fees.

AXA Health Concierge provides customers with diversified and convenient treatment options, this network builds upon the previously launched “GBA Cancer Medical Concierge Service Network” and “GBA Endoscopy Medical Concierge Service Network,”

For further details about “AXA Health Concierge”, please visit: https://www.axa.com.hk/en/greater-bay-area-medical-concierge-service-network

[1] Applicable to eligible insured persons covered under designated medical insurance plans starting from 28 July 2025, including: AXA WiseGuard Pro Medical Insurance – Basic Plan / Supplementary Contract, Global Elite Medical Plan / Global Elite II Medical Plan, GlobalReach Medical Insurance Plan, MediPartner Health Plan, or the AXA WiseGuard Medical Insurance Plan, Smart Medicare or AXA Employee Benefits Insurance Scheme in Hong Kong; and AXA WiseProtect Pro Medical Insurance Plan – Basic Plan/Supplement Plan, Global Elite Medical Plan / Global Elite II Medical Plan, GlobalReach Medical Insurance Plan, MediPartner Health Plan, Smart Medicare or AXA Employee Benefits Insurance Scheme in Macau.

[2] Not applicable to AXA Employee Benefits Insurance Schemes.

[3] The “Medical Green Pass” is not applicable to eligible persons who suffer from acute illness, have been involved in an accident, or require urgent or immediate medical assistance. AXA will arrange hospitalization or outpatient consultation as soon as practicable but cannot guarantee the specific time available for appointment.

[4] The Hospital Authority – Specialist outpatient new case waiting times  during 1 April 2024 – 31 March 2025

[5] BBC News: “Cross-Border Consumption” Extends to “Cross-Border Medical Travel” – The Surprises and Challenges for Hongkongers

[6] “Market First” is based on AXA’s internal market research regarding the “Medical Green Pass” services available in the market. AXA provides patients with prioritised medical appointments at designated hospitals and healthcare networks in Hong Kong and mainland China, ensuring they receive the necessary medical care more swiftly. (Data as of 22 May 2025).

[7] The discounted outpatient consultations only covers the outpatient consultation fee and does not include the cost of medicines and other medical examinations. 

[8] The “Market first” is based on an internal market survey conducted by AXA on 27 Jun 2025, comparing it with similar types of “outpatient discount” offered in the Hong Kong market. The outpatient discount service will be unconditionally extended to the immediate family members of eligible AXA customers. Terms and conditions apply, please refer to the relevant webpage for details.

[9] “Immediate family members” refers to the insured/policyholder’s lawful spouse, children or parents.

About AXA Hong Kong and Macau

AXA Hong Kong and Macau is a member of the AXA Group, a leading global insurer with presence in 50 markets and serving 95 million customers worldwide. Our purpose is to act for human progress by protecting what matters. 

As one of the most diversified insurers in Hong Kong, we offer integrated solutions across Life, Health and General Insurance. We are the largest General Insurance provider and a major Health and Employee Benefits provider. Our aim is to not only be the insurer to provide comprehensive protection to our customers, but also a holistic partner to the individuals, businesses and community we serve. At the core of our service commitment is continuous product & service innovation and customer experience enrichment, which is achieved through actively listening to our customers’ needs and leveraging and investing in technology and digital transformation. 

We embrace our responsibility to be a driving force against climate change and a force for good to create shared value for our community. We are proud to be the first to address the importance of mental health through different products and services and thought leading iconic research. Our overall Sustainability Strategy, with emphasis on climate strategy and biodiversity commitment, is developed based on TCFD recommendations. We are committed to integrating environmental, social and governance factors across our business and strive to contribute to a sustainable future through 3 distinct roles – as an investor, an insurer and an exemplary company.

THIS PRESS RELEASE IS AVAILABLE ON AXA’S WEBSITE: AXA.COM.HK

IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS

Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause AXA’s actual results to differ materially from those expressed or implied in the forward-looking statements. Please refer to Part 4 – “Risk factors and risk management” of AXA’s Universal Registration Document for the year ended December 31, 2019, for a description of certain important factors, risks and uncertainties that may affect AXA’s business, and/or results of operations. AXA undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise, except as part of applicable regulatory or legal obligations.

Breaking Through Core CT Technology Barriers!

World-Class Innovations to Debut at 2025 Medtec in September

SHANGHAI, Aug. 4, 2025 /PRNewswire/ — A quiet revolution is underway in the field of high-end medical equipment, led by China’s growing innovation power. Core CT technologies, once dominated by international giants, are now being steadily unlocked by Chinese companies, breaking through long-standing technical barriers. As a key showcase of this industrial transformation, the 2025 Medtec International Medical Device Design & Manufacturing Technology Exhibition will take place from September 24 to 26 at Halls 1 & 2, Shanghai World Expo Exhibition and Convention Center.

The exhibition will reach a record-breaking scale of 45,000 square meters, bringing together over 1,000 top-tier companies from nearly 27 countries and regions around the world. Among the standout participants, Shanghai Xixin Medical Technology Co., Ltd., Guangzhou Wiserscope Photoelectric Medical Technology Co., Ltd., Wuxi Innosonics Medical Technology Co., Ltd., SmartVein (Jiaxing) Medical Technology Co., Ltd., and Shanghai AIMIC Medical Electronics Co., Ltd. will make major appearances, showcasing their latest technological breakthroughs and product applications to a highly targeted audience of professional buyers. Click to Register for FREE >

01. CT X-Ray Tubes: From Industry Bottleneck to the Rise of “Domestic Cores”

In the realm of high-end medical devices, CT scanners are often referred to as the “eyes of modern medicine”—their performance directly impacts image quality and equipment lifespan. At the heart of these systems, the X-ray tube and detector act as the “retina” and “lens.” For years, these critical components have been dominated by global giants like GE, Siemens, and Philips. As a result, Chinese medical institutions have faced costly challenges—millions spent on consumables and equipment outages lasting over a month while waiting for repairs.

Now, change is underway. In the first half of 2025, the number of registered domestic CT devices surged by 47% year-over-year. Even more significant, the localization rate of core components has crossed the 60% threshold—a historic milestone. Behind this achievement lies the power of collaborative innovation, driven by coordinated efforts among upstream and downstream enterprises across the industry chain:

  • X-ray Tube Technology: Companies like Kunshan Medical Source and Beijing SmartBeam has successfully achieved mass production and installation of 3–5 MHU mid-range X-ray tubes. Meanwhile, Chronos’ 8 MHU liquid metal bearing tube (AU240) has broken the foreign monopoly in the high-end segment, boasting a 20% higher heat dissipation recovery rate compared to imported models.
  • Detector Technology: iRay Technology, in collaboration with the Chinese Academy of Sciences, has developed cadmium zinc telluride (CZT) crystals with a purity of 99.9999%. These detectors have achieved a quantum detection efficiency (DQE) exceeding 92%, enabling a 50% reduction in radiation exposure for low-dose CT scans.
  • High-Voltage Generators: Shenzhen Anke has developed silicon carbide-based power devices capable of controlling voltage fluctuations within ±0.01%, reaching a world-leading standard in precision and stability.

02. Localization Accelerates for the “Core” of CT Systems

Driven by the rapid growth of China’s healthcare industry and an aging population, domestic demand for CT systems and X-ray tubes continues to surge. Today, China has become the world’s largest consumer market for medical CT tubes. According to recent medical procurement data, domestic CT system sales in 2024 have caught up with those of imported brands, with Chinese manufacturers now leading the market in share.

Often referred to as the “core” of the CT system, the X-ray tube is a vital component in the medical imaging supply chain—accounting for roughly 20% of a CT system’s bill of materials (BOM). As a high-value consumable, CT tubes typically need replacement every two and a half years. In high-volume hospitals, that replacement cycle can shorten to just one year. From 2022 to 2024, domestic demand for medical CT tubes was 12,275, 12,317, and 12,713 units, respectively—marking a 3.57% increase in 2024 compared to 2022.

As a critical high-value consumable in medical CT equipment, a single CT tube can cost up to several million yuan. Data shows that the average lifespan of a CT tube in China is just 13 months—effectively requiring replacement nearly every year. The real challenge in CT tube manufacturing lies in achieving exceptional precision and stability. Given their high cost and short service life, CT tubes have become a competitive focal point between CT system manufacturers and tube suppliers.

Domestic companies such as Kunshan Medical Source, CETC, Beijing SmartBeam, and Zhuhai Rcan have secured registrations for multiple CT tube models. For local CT system manufacturers, adopting domestically produced tubes offers a key technological advantage in reducing costs and boosting overall market competitiveness. Since the 12th Five-Year Plan, China has consistently identified CT tubes as a strategic focus for innovation and development. They have remained a priority across three consecutive national Five-Year Plans, underscoring strong government support for advancing homegrown CT tube manufacturing.

At the same time, centralized procurement of medical devices is expanding across the country, with the trend gaining momentum. While global giants like GE Healthcare, Siemens Healthcare, and Philips still dominate the mid- to high-end market, they are increasingly facing pressure from rising domestic competitors. Backed by supportive policies and the growing strength of local technologies, the market share of domestically produced CT core components is expected to see steady and sustained growth.

03. 2025 Medtec: Discover Trends, Connect Resources, Unlock Opportunities

Breakthroughs in independent innovation are not only transforming the domestic landscape but also offering fresh perspectives and solutions to the global medical technology community. The rapid advancement of localized CT core components marks a major milestone in the evolution of China’s medical device industry. 2025 Medtec – the International Exhibition for Medical Device Design & Manufacturing Technology – will serve as a dynamic platform for technical exchange and business collaboration, further accelerating the localization and commercialization of CT core technologies.

From domestically developed medical chips to automated precision components, and from non-invasive brain-computer interfaces to nanoscale surgical robots, 2025 Medtec will showcase a full spectrum of cutting-edge medical technologies from around the world. The event offers professionals a unique opportunity to engage in in-depth technical exchanges and gain insights that span from theoretical innovation to real-world industrial applications.

Additionally, 2025 Medtec will host an enhanced Medtec International Medical Device Supply Chain Ecosystem Summit, centered on eight key themes: high-end active medical devices, manufacturing processes, innovative material applications, R&D consulting, medical regulations, consumer healthcare, market and procurement, and support services. This summit will foster collaboration and innovation throughout the supply chain. Attendees will have the chance to hear the latest industry insights, engage in direct discussions with experts, and explore new opportunities and challenges shaping the future of the medical device industry.

We invite industry professionals from around the world to register and attend this exhibition—come witness the rapid rise of China’s CT core component industry and see firsthand how the “heart” of China’s high-end medical equipment is beating stronger than ever, showcasing Chinese innovation and strength on the global medical device stage!